|
|
Consultant mental health physician and a certified addiction treatment specialist
Plenary 3: A Focus on Treatment and Recovery
Case Studies of Treatment Programmes in Latin America/Caribbean and Africa
|
|
|
Head of Social Welfare, Vulnerable Groups and Drug Control, African Union Commission
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
Continental Perspective – An Overview of Drug Use in Africa
|
|
|
Senior Independent Consultant, Drug Epidemiology, African Union Commission
Plenary 4: Epidemiology and its Role in Drug Demand Reduction
Co-chair
|
|
|
Senior Drug Control Programme Officer, African Union Commission
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
African Union Plan of Action on Drug Control and Crime Prevention (2019-2023)
|
|
|
Commissioner for Social Affairs, African Union Commission (AUC)
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
Setting the Scene
|
|
|
President, ISSUP Argentina
Plenary 4: Epidemiology and its Role in Drug Demand Reduction
Overview of Drug epidemiology in Latin American and the Caribbean
|
|
|
Regional Advisor on Alcohol and Substance Abuse, Pan-American Health Organization (PAHO) Focus on the African context
Plenary 2: Evidence-Based Prevention: Policy and Practice
Alcohol Use Prevention (data on alcohol use and environmental prevention initiatives)
|
|
|
Executive Secretary, Inter-American Drug Abuse Control Commission (CICAD), Organization of the American States (OAS)
|
|
|
Director, Centre for Research and Information on Substance Abuse, Nigeria
Plenary 4: Epidemiology and Its Role in Drug Demand Reduction
A Continental Overview of Drug Epidemiology in Africa
|
|
|
Oskamp Professor of Social Psychology, Division of Behavioral and Organizational Science, Claremont Graduate University
Plenary 2: Evidence-based Prevention: Policy and Practice
Media-Based Prevention Programmes
|
|
|
![Olubusayo Akinola](/files/inline-images/Olubusayo%20Akinola_3.jpg)
Programme Officer, Drug Demand Reduction, ECOWAS Commission
Plenary 4: Epidemiology and Its Role in Drug Demand Reduction
Regional Perspectives
|
|
|
Senior Advisor, Office of Global Policy and Programs, Drug Demand Reduction, INL, U.S. Department of State
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
Global Initiatives by the Bureau of International Narcotics and Law Enforcement Affairs, US State Department
|
|
|
Senior Consultant, ISSUP Global
Plenary 2: Evidence-based Prevention: Policy and Practice
What Constitutes Evidence-Based Prevention?
|
|
|
Training Coordinator for Africa, Colombo Plan DAP
Plenary 3: A Focus on Treatment and Recovery
Best Practices in Treatment and UTC training in Africa
|
|
|
![David Bayever](/files/inline-images/David%20Bayever.jpg)
Assessor, Examiner and Researcher for the SAPharmacy Council
Plenary 2: Evidence-based Prevention: Policy and Practice
Plenary Chair
|
|
|
Chief, Prevention, Treatment & Rehabilitation Section, UNODC
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
Global Perspective – A Global Overview of Drug Use
Plenary 2: Evidence-based Prevention: Policy and Practice
Prevention Standards
|
|
|
Associate Professor and Head of Department, Department of Epidemiology and Biostatistics, Makerere University School of Public Health, Uganda
Plenary 2: Evidence-based Prevention: Policy and Practice
Alcohol Use Prevention (data on alcohol use, environmental prevention initiatives)
|
|
|
Programme Officer, Prevention, Treatment and Rehabilitation Section, UNODC
Plenary 3: A Focus on Treatment and Recovery
Treatment Standards
|
|
|
Chief, Data Development and Dissemination Unit, UNODC
Plenary 4: Epidemiology and Its Role in Drug Demand Reduction
Synchronising Global Drug Epidemiology Data Collection
|
|
|
Chief, Inter-American Observatory on Drugs, CICAD
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
Regional Perspective – Latin America and the Caribbean
|
|
|
Research Specialist, Inter-American Observatory on Drugs, CICAD - Caribbean
Plenary 4: Epidemiology and Its Role in Drug Demand Reduction
Overview of Drug Epidemiology in Latin America & Caribbean
|
|
|
Programme Manager, Substance Abuse Prevention and Drug Control Rehabilitation Division, Social Welfare Services Directorate, Ministry of Health and Social Services, Namibia
Plenary 2: Evidence-based Prevention: Policy and Practice
Alcohol Use Prevention (data on alcohol use, environmental prevention initiatives)
|
|
|
Director, Global Centre for Credentialing and Certification (GCCC), Colombo Plan DAP
Plenary 3: A Focus on Treatment and Recovery
Credentialing and Certification
|
|
|
Chief, Drug Research Section, Research Branch, UNODC
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
Global Perspective – A Global Overview of Drug Use
Plenary 4: Epidemiology and Its Role in Drug Demand Reduction
Synchronising Global Drug Epidemiology Data Collection
|
|
|
Deputy Director, Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council
Plenary 3: A Focus on Treatment and Recovery
Service Quality Measurements in Treatment Facilities
|
|
|
Foreign Affairs Officer, Office of Global Policy and Programs, Drug Demand Reduction, INL, U.S. Department of State
Plenary 1: Setting the Scene for Drug Demand Reduction in Africa
Global Initiatives by the Bureau of International Narcotics and Law Enforcement Affairs, US State Department
|
|
|
Executive Director of Mental Health, Ministry of Health, Peru
Plenary 3: A Focus on Treatment and Recovery
Case Studies of Treatment Programmes in Latin America/Caribbean and Africa
|
|
|
Professor and Acting HOD, Department of Psychology, University of Johannesburg, South Africa
Plenary 2: Evidence-based Prevention: Policy and Practice
Alcohol Use Prevention (data on alcohol use, environmental prevention initiatives)
|
|
|
![Ms Hendrietta Bogopane-Zulu](/files/inline-images/Hendrietta%20Ipeleng%20Bogopane-Zulu_0.png)
Deputy Minister, Republic of South Africa Department of Social Development (DSD)
Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction
Plenary Chair
|
|
|
![Seth Kwame Acheampong](/files/inline-images/Seth%20Kwame%20Acheampong_1.png)
Chairman, Defence and Interior Committee, Parliament of Ghana
Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction
Role of the Legislator in Drug Demand Reduction
|
|
|
Illinois State Senator, USA
Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction
Role of the Legislator in Drug Demand Reduction
|
|
|
President of the Commission of Autonomous Governments, Decentralization, Competences and Territorial Development of the Assembly
Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction
Role of the Legislator in Drug Demand Reduction
|
|
|
Research Scientist, South African Medical Research Council, SENDU/SACENDU
Plenary 4: Epidemiology and Its Role in Drug Demand Reduction
Regional Perspective
|
|
|
Professor at the Centre for Traditional Medicine and Drugs Research, Kenya
Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction
Role of Traditional Health Practitioners and Leaders in Drug Demand Reduction (Roundtable Discussion)
|
|
|
|
|
|
|
|
|
|